Activation of mitosis-promoting factor (MPF) drives mitotic commitment 1 . In human cells active MPF appears first on centrosomes 2 . We show that local activation of MPF on the equivalent organelle of fission yeast, the spindle pole body (SPB), promotes Polo kinase activity at the SPBs long before global MPF activation drives mitotic commitment. Artificially promoting MPF or Polo activity at various locations revealed that this local control of Plo1 activity on G2 phase SPBs dictates the timing of mitotic commitment. Cytokinesis of the rod-shaped fission yeast cell generates a naive, new, cell end. Growth is restricted to the experienced old end until a point in G2 phase called new end take off (NETO) when bipolar growth is triggered 3 . NETO coincided with MPF activation of Plo1 on G2 phase SPBs (ref. 4). Both MPF and Polo activities were required for NETO and both induced NETO when ectopically activated at interphase SPBs. NETO promotion by MPF required polo. Thus, local MPF activation on G2 SPBs directs polo kinase to control at least two distinct and temporally separated, cell-cycle transitions at remote locations.
the Plo1 that associates with SPBs during G2 phase of both wild-type and cut12.s11 cells is active 8 . Prompted by the fact that the enhancement of Plo1 activity that accompanies mitotic commitment is driven by MPF activation 9 , we now address the function of this SPB-associated Plo1 in mitotic control.
MPM2 or Plo1 immunofluorescence staining reveals single (late G2 phase) or paired foci (mitotic) of SPB staining. The ratio of 1:2 foci (G2/Mitotic) in cell populations gives an indication of the point in G2 at which Plo1 is recruited to (Plo1 staining), or activated at (MPM2), SPBs. Staining patterns in an established plo1.GFP strain 10 revealed that the fusion of GFP sequences to the carboxy terminus of Plo1 did not alter the timing or activation of Plo1 at SPBs (Fig. 1a) . Time-lapse imaging revealed that Plo1 was initially recruited around 30 min before mitosis (Fig. 1a-c ). This initial recruitment was advanced by a further 30 min in cut12.s11 cells (Fig. 1a-c and Supplementary Video S1). Fluorescence recovery after photobleaching (FRAP) revealed a rapid turnover of Plo1.GFP (half-life 21-22 s) at the SPBs of both cut12 + and cut12.s11 cells ( Fig. 1d and Supplementary Video S2).
To assess the impact of MPF activity on Plo1 SPB recruitment we exploited the cdc2.as mutation in the catalytic subunit of MPF that renders it sensitive to inhibition by ATP analogues 11 . plo1.GFP cdc2 + cells were labelled by transient immersion in fluorescent lectin 12 and mixed with plo1.GFP cdc2.as cells for live-cell imaging. Addition of the ATP analogue 1NA-PP1 prompted the immediate loss of Plo1.GFP from G2 SPBs of cdc2.as cells whereas it persisted on the G2 SPBs of neighbouring cdc2 + cells (Fig. 1e ,f and Supplementary Videos S3 and S4). Restoration of MPF activity by removal of the analogue promoted a rapid return ( Fig. 1f and Supplementary Video S4), indicating that MPF activity is continuously required for Plo1 association with the late G2 SPB.
We extended the analogue-sensitive approach to assess the contribution of Plo1 activity to mitotic control in unperturbed Time ( + (h) cells were split into three following completion of the first synchronous division after size selection and treated as indicated in the legend to the graphs before processing for immunofluorescence microscopy with phospho-histone H3 Ser 10 antibodies. The analogue 3-BrB-PP1 was added to a final concentration of 20 µM. The numbers in time-lapse images indicate minutes.
cell cycles. In strains harbouring the plo1.as1, plo1.as2, plo1.as3 or plo1.as4 mutations that are predicted to confer sensitivity 13 , addition of analogue had little impact on the most sensitive readout of Plo1 function, spindle formation 14 . However, septation was compromised in the first division after the addition of 40 µM 3MB-PP1 to plo1.as3 cells (data not shown), indicating a modest degree of sensitization 14 . We therefore studied the structure of AMP-PNP-bound human Plk1 (ref. 15) to seek notable differences between the structure of this mammalian kinase that can be sensitized to ATP analogue inhibition and its refractory fission yeast counterpart, Plo1. Plk1 harbours a phenylalanine at position 170 at the bottom of the ATP-binding pocket that is replaced by methionine in Plo1. Mutation of this methionine to phenylalanine in a plo1.as3 backbone created the plo1.as8 allele that responded to 3MB-PP1 or 3-BrB-PP1 addition by arresting mitotic progression with the monopolar spindle phenotype that is a characteristic of severely compromised Plo1 function 14 ( Supplementary  Fig. S1a,b) . Addition of 20 µM 3-BrB-PP1 to G2 plo1.as8 cells delayed the phosphorylation of histone H3 Ser 10 that accompanies mitotic commitment by 40 min (Fig. 1g,h ).
Plo1 comprises a catalytic domain and two polo boxes that direct the kinase to target molecules that are either direct substrates or platforms from which neighbouring substrates can be phosphorylated [16] [17] [18] ( Supplementary Fig. S1c ). We reasoned that Plo1 could be directed to a site of choice by replacement of the polo boxes with a surrogate targeting sequence. We replaced the polo box domain of plo1.as8 with sequences encoding the GFP-binding protein [19] [20] [21] (GBP), in a transgene that was expressed from an ectopic location. We incorporated mutations conferring constitutive activation 8 into the catalytic domain of this hybrid molecule to override the controls that normally coordinate Plo1 activity with cell-cycle progression ( Supplementary  Fig. S1c ). Ectopic expression of this Plo1.RL chimaera in the presence of inhibitory ATP analogue targets a restrained kinase to any location that hosts GFP (Supplementary Fig. S2a ). Subsequent analogue removal releases sustained Plo1 kinase activity at the target site. This approach enabled us to uncouple kinase activation from its normal cell-cycle context and to examine which events are triggered by forced Plo1 activation at a particular location.
Plo1.RL activation at SPBs through recruitment to Cut12.NEGFP promoted mitotic commitment (Fig. 2a) . A lower level of mitotic induction arose from recruitment to the SPB components Pcp1.GFP and Sid4.GFP whereas none followed targeting to any other location ( Fig. 2a and Supplementary Fig. S2b ). Bleaching the fluorescence signal derived from either the host molecule Cut12.NEGFP or the associated Plo1.RLTom chimaeric kinase revealed no turnover of the Cut12.NEGFP/Plo1.RLTom complex at SPBs (Fig. 2b) . We therefore investigated whether the anchored Plo1.RL chimaeric kinase relied on the endogenous, mobile, Plo1 to promote mitotic commitment. plo1.ts41 cells ( Supplementary Fig. S1e,f) harbouring Cut12.NEGFPanchored Plo1.RL were shifted from 25
• C to 36
• C to inhibit Plo1 function as the inhibitory analogue was removed. Different induction times produced different levels of Plo1.RL at this point of release. Levels of Plo1.RL (18 or 20 h induction) that were competent to induce mitosis when the endogenous Plo1 kinase was a functional wild-type molecule were unable to do so when it was the incapacitated Plo1.ts41 (Fig. 2c) .
As MPF associates with G2 SPBs (refs 22,23) and controls SPB recruitment of Plo1 (Fig. 1e,f) , we investigated whether it was also responsible for generating the pro-mitotic Plo1 signal at SPBs. We examined this possibility with a Cdc2-GBP fusion protein, Cdc2.RL (cdc2.F84GY15F, Supplementary Fig. S1c ) that is insensitive to inhibition by either Mik1 or Wee1 (ref. 24 ) and sensitive to ATP analogues 11 . Activation of Cdc2.RL by analogue removal from strains in which the chimaeric kinase had been recruited to a variety of locations ( Supplementary Fig. S3a ) mirrored the Plo1.RL data: SPB recruitment through Cut12.NEGFP gave a strong induction of mitosis; weaker levels followed SPB recruitment with either Pcp1.GFP or Sid4.GFP and no induction was seen following recruitment to any other location ( Fig. 2d and Supplementary Fig. S3b ). Bleaching Cut12.NEGFPanchored Cdc2.RLTom revealed a static association with the SPBs (Supplementary Fig. S3c ). MPM2 reactivity of SPBs showed that the wave of mitosis that arose from activation of Cut12.NEGFP-anchored Cdc2.RL was preceded by Plo1 activation (Supplementary Fig. S3d ). Consistently, this ability of Cut12.NEGFP-anchored Cdc2.RL to induce mitosis relied on Plo1 activity (Fig. 2e) .
Three further Cut12.NEGFP/Cdc2.RL experiments were informative. When the cdc2 encoding sequence retained Tyr 15 (Cdc2.RLY15, Supplementary Fig. S1c ), mitosis was not induced (Fig. 2f) , indicating that the balance of Wee1 and Cdc25 activities normally determines the timing at which SPB-bound MPF activity is enhanced to trigger mitosis. Mitotic induction by SPB-tethered Cdc2-RL was blocked in a cdc2.33 background in which the bulk population of MPF within the nucleus 22, 23 was inactivated (Fig. 2g,h ), even though Plo1 activity was promoted on the SPBs of these interphase cells (Fig. 2i) . Thus, division is not driven from the SPB, rather MPF activation at the SPB serves as a trigger event that promotes conversion of the bulk population MPF throughout the cell 22, 23 to the active state. The second wave of mitosis after analogue removal was abolished by the inclusion of hydroxyurea in the replacement, analogue-free, medium (Fig. 2f) , indicating that the checkpoint remains intact.
The point in G2 phase at which Plo1 was initially recruited to G2 SPBs is strongly influenced by cell density (Fig. 1a) . Consistently, nutrient provision and TOR signalling is closely tied to SPB recruitment of Plo1 in mitotic control [25] [26] [27] [28] . This context dependency is highly reminiscent of the way by which the timing of the G2 event NETO changes in response to changes in nutrient supply 3 . We therefore examined the relationship between Plo1 recruitment to the G2 SPB and NETO. Strikingly, the two events were coincident: in counts of 100 cells, every post-NETO G2 cell exhibited a Plo1.GFP signal at its SPB whereas neighbouring pre-NETO cells had none (Fig. 3a) . The correlation between NETO and Plo1 recruitment was even maintained when Plo1 SPB recruitment was advanced by 30 min by cut12.s11 (Fig. 3b) .
To determine whether there was a direct causal relationship between Plo1 activity and NETO, NETO was monitored when small G2 plo1.ts41 cells ( Supplementary Fig. S1e ,f) were shifted from 25
• C to 36 • C. NETO execution was severely compromised by Plo1 inactivation (Fig. 3c and Supplementary Fig. S1g ). To determine whether it was the SPB-associated pool of Plo1 that triggered NETO, we targeted Plo1.RL to various locations in cdc10.v50 cells. At 36
• C, cdc10.v50 arrests cell-cycle progression in G1 phase before NETO (ref. 3) . NETO was triggered when Plo1.RL was activated at the SPBs of cdc10.v50 cells but nowhere else, including recruitment to the cell end itself through either Tea1.v5GFP or For3.GFP fusion proteins ( Fig. 3d and Supplementary Fig. S2a ). The observation that G2-arrested cdc2.33 cells undergo NETO (ref. 3 ), yet NETO can be triggered by Plo1 activation on SPBs (an MPF-dependent event; Fig. 1e-f ), prompted us to re-examine the relationship between NETO and Cdc2 with the cdc2.as allele. Addition of 1 µM BrB-PP1 to G2 cdc2.as cells mimicked temperature-mediated inactivation of cdc2.33 in having no impact on NETO yet arresting cell-cycle progression in G2. However, a stronger level of inhibition (20 µM BrB-PP1) did block NETO ( Fig. 4a and Supplementary Fig. S4 ), indicating that the threshold of MPF activity required for NETO was lower than that for mitotic commitment.
The contribution of SPB-associated MPF to the promotion of NETO cannot be assessed by the Cdc2.RL approach in wild-type cultures because the immediate induction of mitotic commitment ( Fig. 2d ) obscures any impact on NETO. We therefore blocked the propagation of the mitotic commitment signal with the cdc2.33 mutation (Fig. 2h) • C for 1 h to inactivate Cdc2.33 before analogue removal activated the SPB-associated Cdc2.RL (Fig. 4b) . NETO was triggered by Cdc2.RL activation on the SPB, but at no other location. Recruitment to Cut12 had a greater impact than to Pcp1 or Sid4 (Fig. 4c and Supplementary Fig. S3e ). Critically, this ability of Cut12.NEGFP-anchored Cdc2.RL to induce NETO was reliant on Plo1 activity (Fig. 4d) . It also required the polarity factors Tea1, Bud6 and Sla2 (Fig. 4e) . We propose that Plo1 recruitment to SPBs in G2 phase both triggers the cell-cycle-dependent morphogenetic switch to bipolar growth and constitutes a priming event that licenses the cell to regulate the timing of mitotic commitment. The MPF dependency and activity of the Plo1 recruited to these G2 SPBs suggests a local activation of the feedback loops that will later be employed at remote locations to drive the global cell cycle during mitotic commitment (Fig. 5a ). As NETO happens as soon as the feedback loop is running on the SPB the target/s for Plo1 in NETO control probably differ from those in G2/M commitment control. The fact that it is only constitutively active forms of MPF that can override the normal controls to induce mitosis and NETO (a) The absence of a readout for MPF activity on the SPB in early G2 means that it is not possible to propose activity at this site before activation/enhancement promotes Plo1 turnover in late G2 (left). MPF feedback loop enhancement/activation on the G2 SPB subsequently triggers the pathway that ultimately leads to NETO, yet this level of G2 activation is insufficient to trigger mitotic commitment (centre). Mitosis is triggered later when there has either been a reduction in the level of inhibition by Wee1 or phosphatases such as PP2A and the Cdc14 homologue Flp1/Clp1 or feedback loop activity is enhanced to exceed an inhibitory threshold, or a combination of the two (right). It is likely that the different pathways that impact on the timing of mitotic commitment will target different parts of this switch. (b) The spatial organization of Plo1 activation on the SPB relative to the Pom1/Cdr1/Cdr2 pathway that couples tip extension to mitotic commitment 29, 30 . Note that the close relationship between the position of the Cdr1/Cdr2/Wee1 nodes and the position of the nucleus that is established by the cycles of nuclear import/export of Mid1 places this inhibitory network directly over the SPB, putting it in the optimal location to dampen/neuter the pro-mitotic signal emerging from the SPB.
when targeted to the SPB (Fig. 2f and Supplementary Figs S2d,e and S3f) indicates that Wee1 activity blocks the propagation of the mitotic commitment signal from the SPB.
Once the restraining activity of Wee1 is removed/overcome, cells can execute mitosis. Given the relative location of the different signalling components, it would seem likely that the anti-mitotic activity of the equatorial belt of inhibitory nodes that contain Cdr1, Cdr2 and Wee1 and encircle the nucleus blocks the propagation of the signals emanating from the SPB (Fig. 5b ) 29, 30 . The well-documented ability of TOR signalling to influence the timing of mitotic commitment in fission yeast relies on its ability to promote Plo1 recruitment to the SPB (refs 25-28), indicating that, in some situations, enhancing the level of Plo1 signalling from the SPB is sufficient to advance the timing of mitotic commitment. Perhaps mitotic commitment is also finally triggered when Plo1 activity exceeds a critical threshold in unperturbed cell cycles.
As NETO ensures that each daughter cell will receive an experienced, old, cell tip that will be optimal for growth in the subsequent cell cycle, Plo1 recruitment to G2 SPBs could be seen as the first phase of mitotic commitment. However, the question remains as to how a signal that emanates from the cell equator triggers an event at the cell extremity (NETO). A recent study may hold the clue 31 . The Cdc42 activation that drives tip growth is not a persistent signal at one end. Rather, it alternates between the two cell tips throughout interphase. Thus, Cdc42 is activated at new ends every 3 min throughout early G2 up to NETO. However, NETO is triggered only once global Cdc42 activity exceeds a critical threshold level of global Cdc42 activation. A general signal emanating from the SPB could set the level of this general threshold by targeting Cdc42 or its regulators globally.
Given the impact of TOR and stress pathways on SPB recruitment of Plo1 (refs 26,27,32) and the coordination of cytokinetic ring formation and function by a second cell-cycle regulatory network on the same SPBs (the septum initiation network 33 ), we propose that the SPB (and by implication the centrosome) acts as a platform at which signals from diverse signalling pathways are integrated to generate coordinated and coherent signals to control cell-cycle progression.
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Cell culture and growth. Strains used in this study are listed in Supplementary   Table S1 . Cells were grown and maintained according to ref. 34. Appropriately supplemented EMM2 synthetic medium was used for all experiments. As cell density alters the nutritional environment of the cell, which, in turn, influences the timing of Plo1 recruitment to the SPB (Fig. 1a) , all measurements of Plo1.GFP recruitment were conducted with prototrophs in filter-sterilized supplemented EMM2 at 25 • C. Centrifugal elutriation was used to isolate small G2 cells 35 . All such synchronized cultures were diluted to a concentration of 1 × 10 6 cells ml −1 after elutriation. ATP analogues 36 (Toronto Research Chemicals, Dalton Pharma Services) were dissolved in methanol to generate 50 mM stock solutions that were subsequently added to cultures. Removal of analogue from the cell environment was achieved by filtration of the cells from culture followed by re-suspension in an identical volume of pre-warmed analogue-free medium.
Microscopy/FACS analysis. Tubulin, Sad1, MPM2 and anti-histone H3 phosphoSer 10 immunofluorescence and calcofluor or phalloidin staining were conducted using established procedures 3, 8, [37] [38] [39] . Affinity-purified polyclonal Sad1 antibodies 37 were used at a concentration of 1 in 25 and the dilution of tissue culture supernatant containing the TAT1 monoclonal antibody 40 (gift from K. Gull, University of Oxford) was 1 in 80. Antibodies that recognized histone H3 when phosphorylated on Ser 10 were generated and affinity purified by Eurogentec and used at a concentration of 1 in 100. MPM2 antibody (Upstate 05-368) that recognized a phospho-epitope on the SPB that is dependent on Plo1 phosphorylation 8, 41 was used at a concentration of 1 in 100. For detection of the V5 epitope in Plo1.RL and Cdc2.RL molecules polyclonal antibodies against the epitope (Bethyl Laboratories A190-120A) were used at a concentration of 1 in 100 following fixation with 4% formaldehyde for either 10 (Cut12, Pcp1, Sid4, Cnp1) or 30 (Crn1, Cut3, Nup85, Nup189) minutes. Thirty minutes in 4% formaldehyde was also used to detect Plo1.RL in Tea1.GFP cells in which the presence of the SV5 epitope in the fusion protein forced us to detect the hybrid molecule with Plo1 polyclonal sera at a concentration of 1 in 100 (ref. 4) . DNA content analysis through FACS used Cytox green (Invitrogen) according to published procedures 42 .
Western blotting. Plo1 polyclonal antisera 43 were used at a concentration of 1 in 500. PN24 anti-Cdc2 polyclonal antisera were used at a concentration of 1 in 500 to detect Cdc2. Polyclonal antibodies against the SV5 epitope (V5) were used at a concentration of 1 in 500.
Live-cell imaging. All quantitative microscopy was conducted on a DeltaVision system (Applied Precision) fitted with a Zeiss ×100, 1.45 NA objective in conjunction with Softworx (Applied Precision) and Imaris (Bitplane) software. Cells were mounted in a Bioptechs FCS2 chamber. The images shown are maximal projections of 20 sections, with 0.3 µm between the slices; images were taken every 3 min. For the FRAP analysis images were taken every second. Qualitative assessment of analogue addition on Plo1.GFP recruitment in cdc2.as was conducted on either DeltaVision or on an Olympus/Photometrics spinning-disc confocal microscope with Metamorph software. Cells were mounted in glass-based culture plates (Iwaki 5826-024) and media exchanged by aspiration with a Pasteur pipette. A 532 nm 25 mW laser was used to bleach the red fluorescence signal of the Tomato constructs and a 488 nm 25 mW laser bleached the green fluorescence emanating from Plo1 and Cut12 GFP fusion proteins.
Genetic manipulation. plo1.ts41 was generated as described previously 44 with the exception that screening for temperature-sensitive mutants was conducted at 32 • C rather than 36 • C. The plo1.as8 allele incorporates the canonical as3 mutations 13 alongside a mutation of methionine to phenylalanine at position 170. This last change was selected because the crystal structure of human Plk1 AMPPNP (ref. 15 ) identified this residue as being a major difference between the established Plk1 structure (Plk1.as3 can be strongly inhibited by ATP analogues) and the predicted structure of Plo1 (Plo1.as3 is not strongly inhibited by ATP analogues; data not shown). plo1.as8 was integrated at the native locus using the marker switch approach 44 . To create Plo1.RL, the S124D and T197D mutations that confer constitutive activation 8 were introduced into plo1.as8, and the polo box domain (position 502-608) was replaced with a GBP (refs 19-21)-SV5 epitope double tag, and integrated the resultant plo1.RL gene into the leu1 locus under the control of the nmt81 promoter. cdc2.RL and cdc2.F84GY15F were created by site-directed mutagenesis and tagged at their C termini with GBP-SV5 before each cassette was introduced into a non-transcribed region of chromosome 3 under the control of the nmt81 promoter. To create cdc2.RLTom and Plo1.RLTom, an Nde1 fragment encoding a functional Tomato fluorescence unit (a dimer of two subunits) was inserted at the amino terminus of cdc2.RL and plo1.RL. All mutant alleles were generated by PCR amplification and QuikChange mutagenesis (Stratagene). 
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Figure S1 plo1 mutants. a) Alignment of the sequences of human Plk1 and Plo1. Plk1 is rendered sensitive to ATP analogues by mutation of the gatekeeper and compensating residues predicted by Zhang et al. 28, 30 while the equivalent plo1.as3 mutation displays only moderate analogue sensitivity (data not shown). The candidates for changes that might enhance the association with AMPPNP in the crystal structure of Plk1 are highlighted: The three arginine residues in the hinge region after the back of the ATP binding pocket that contains the gatekeeper residue (blue) and the phenylalanine at the bottom of the pocket (red). To make the pocket even larger isoleucine 47 was replaced by a smaller glycine. Below the alignment is a summary of the four mutations based on these changes that were introduced into the native plo1 locus and assessed for impact on Plo1 function in response to analogue addition by monitoring the frequency of monopolar spindles in (b). c) The molecular structure of the plo1 and cdc2 alleles, their targeting specificities alongside the scheme used to induce the gene and subsequently activate the "caged" kinase by analogue removal. 3xV5 indicates three copies of the SV5 epitope. The level of Plo1.RL/Cdc2.
RL attained in the 24 hour inductions used in all experiments were similar to those of the native kinases (with the exception of Figure 2c ). (d) A cartoon of the approach used to generate a mutant library of temperature sensitive plo1 alleles. The significant deviation from the approach taken previously to generate such conditional alleles 27 was setting the initial temperature for screening on plates to 32°C, rather than 36°C. Several highly penetrant mutants were identified following this simple modification. (e, f) Combined Sad1 and tubulin immunofluorescence was used to monitor the appearance of monopolar spindles following shift of an asynchronous plo1.ts41 culture from the permissive temperature of 25°C to the restrictive temperature of 36°C at time 0 in the plot in d. f) Tubulin/Sad1/chromatin/DIC micrographs of cells at the 180 min in (d). g) Temperature mediated inactivation of Plo1 and NETO. Datasets from the experiments shown in Figure 3c . Small G2 cells were isolated from plo1.ts41 (upper) or plo1+ (lower) cultures at time 0. After completion of the first division each culture was split and one half shifted to 36°C (Figure 3c ) while the other was maintained at 25°C (right panels). Calcofluor staining was used to score NETO and septation status. Remove thiamine, 24h.
Remove ATP analogue.
Fusion protein is active at specific location. cut3 + encodes a condensin subunit. cnp1 + encodes the centromeric histone H3 variant cenpA. tea1 + encodes a encodes a kelch domain protein that is delivered to cell tips by microtubules where it regulates polarized cell growth. for3 + encodes one of the three fission yeast members of the formin family of actin nucleating proteins. nup85 + and nup189 + encode nuclear core components. brr6 + encodes a nuclear envelope protein that is recruited to the SPB during mitotic commitment to drive integration into the nuclear envelope at mitotic commitment and once more during mitotic exit to co-ordinate the expulsion from the envelope. b-e) Analogue (40mM 3MB-PP1) wash out experiments of the indicated strains as described for Figure 2a. (b) The moderate induction of mitosis following analogue washout in a sid4.GFP background was of a similar amplitude to that seen in pcp1.GFP background, while no induction was seen when Plo1.RL was recruited to any other location. Importantly, no induction was seen upon recruitment to Brr6 indicating that the timing of Plo1.RL recruitment to the SPB is critical. The increase in mitotic index in the cnp1.GFP background arose from compromised chromosome segregation as lagging chromosomes and chromosomes falling off spindles were frequently observed following analogue removal (data not shown). Similarly, cytokinesis was severely disrupted by analogue removal when Plo1.RL was recruited to the actin binding protein coronin (crn1.GFP (Figure 2a Figure  1c) that was used in these experiments lacked the S124D and T197D mutations that conferred constitutive activation (yet retained the analogue sensitizing mutations). No mitotic induction was observed, indicating that Plo1 activity at the SPB is normally subject to tight control to prevent premature mitotic commitment. (e) Calcofluor staining to monitor NETO state (left) and MPM2 staining to monitor Plo1 activity at SPBs (right) as described in Figure 3d . In stark contrast to the data with the constitutively active plo1.RL allele, analogue removal had no impact upon NETO or Plo1 activity on the G2/early mitotic SPBs (single dots) when the constitutive activation mutations were not present in the ectopically expressed chimera. (f) Analogue wash out experiments of the indicated strains as described for Figure 4b ,c with the exception that the cdc2.RLY15 allele that was used in these experiments, while retaining the F84G analogue sensitizing mutation, contained the wild type Y15 in place of the F15 mutation of cdc2.RL (Supplementary Figure 1c) . This cdc2.RLY15 allele therefore retained the ability to be subject to inhibitory phosphorylation by Wee1 kinase. Notably, there was no alteration of NETO status in the culture following the removal of analogue from cells in which this chimeric molecule had been recruited to SPBs via Cut12.NEGFP, establishing that MPF activity on the SPB is normally restrained by Wee1/Mik1 activity to prevent premature triggering of NETO. 40mM 3MB-PP1 was used for the Analogue wash out experiments presented here. Figure 4a . The 25°C panel shows the phenotypes from initial size selection until the splitting of the culture into four equal aliquots at 240 minutes, All cultures were shifted to 32°C to exploit the moderate temperature sensitivity of the cdc2.as mutation 11 and the addition of the ATP analogue 3-BrB-PP1 was used to compromise Cdc2 activity, as indicated, in the right hand panels. (b) Wild type control treatment that mirrored the cdc2.as regime for panel revealed that the addition of the ATP analogue 3-BrB-PP1 had no impact upon the timing of NETO even though 20 mM does lead delay the timing of mitotic commitment to a small degree. (c) A repeat of the experiment presented in Figure 4a in which size selected early G2 cells were allowed to transit one cell cycle before the early G2 cells were split into three aliquots and treated with the ATP analogue 3-BrB-PP1, the solvent methanol, or subjected to no treatment as indicated. The FACS profiles of DNA content show that the two analogue treated cultures remain in a G2 arrested state for the duration of the experiment. This shows that the inhibition of NETO does not arise from a secondary consequence of premature commitment to DNA replication which then blocks NETO via a checkpoint mechanism.
